A 12-year-old male neutered Miniature Poodle with confirmed pituitary-dependent hyperadrenocorticism was treated with trilostane. After three doses, it developed clinical and laboratory changes suggestive of isolated hypocortisolism ('atypical hypoadrenocorticism'), whi... View more
1. Neiger R, Ramsey I, O'Connor J, Hurley KJ, Mooney CT. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002; 150:799-804.
2. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002; 63:506-512.
3. Braddock JA, Church DB, Robertson ID, Watson AD. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Aust Vet J. 2003; 81:600-7
4. Wenger M, Sieber-Ruckstuhl NS, Muller C, Reusch CE. Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitarydependent hyperadrenocorticism Am J Vet Res 2004; 65:1245-50.
5. Barker E, Campbell S, Tebb A, et al. A comparison of the survival times of dogs treated for hyperadrenocorticism with trilostane or mitotane J Vet Intern Med 2005; 19:810-815
6. Kintzer PP, Peterson ME. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1991; 5:182-190.
7. Dunn KJ, Herrtage ME, Dunn JK. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism. Vet Rec 1995; 137: 161-165
8. Chapman PS, Kelly DF, Archer J, Brockman DJ, Neiger R. Adrenal necrosis in a dog receiving trilostane for the treatment of hyperadrenocorticism. J Small Anim Pract. 2004; 45:307-10
9. Hoffman KL Ultrasonographic examination in canine hyperadrenocorticism Aust Vet J 2003; 81: 27-30
10. Russell NJ, Foster S, Clark P, Robertson ID, Lewis D, Irwin PJ. Comparison of radioimmunoassay and chemiluminescent assay methods to estimate canine blood cortisol concentrations Aust Vet J 2007; 85: 487-494